Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO). [electronic resource] by
- Lortholary, A
- Largillier, R
- Weber, B
- Gladieff, L
- Alexandre, J
- Durando, X
- Slama, B
- Dauba, J
- Paraiso, D
- Pujade-Lauraine, E
Producer: 20120522
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
17.
|
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes. [electronic resource] by
- Platzbecker, U
- Symeonidis, A
- Oliva, E N
- Goede, J S
- Delforge, M
- Mayer, J
- Slama, B
- Badre, S
- Gasal, E
- Mehta, B
- Franklin, J
Producer: 20170928
In:
Leukemia vol. 31
Availability: No items available.
|
|
18.
|
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE. [electronic resource] by
- de la Fouchardière, C
- Largillier, R
- Goubely, Y
- Hardy-Bessard, A-C
- Slama, B
- Cretin, J
- Orfeuvre, H
- Paraiso, D
- Bachelot, T
- Pujade-Lauraine, E
Producer: 20100125
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
19.
|
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. [electronic resource] by
- Kosmider, O
- Gelsi-Boyer, V
- Slama, L
- Dreyfus, F
- Beyne-Rauzy, O
- Quesnel, B
- Hunault-Berger, M
- Slama, B
- Vey, N
- Lacombe, C
- Solary, E
- Birnbaum, D
- Bernard, O A
- Fontenay, M
Producer: 20100603
In:
Leukemia vol. 24
Availability: No items available.
|
|
20.
|
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS. [electronic resource] by
- Park, S
- Sapena, R
- Kelaidi, C
- Vassilieff, D
- Bordessoule, D
- Stamatoullas, A
- Cheze, S
- Beyne-Rauzy, O
- Vey, N
- Rose, C
- Guerci, A
- Natarajan-Amé, Shanti
- Tertian, Gérard
- Slama, B
- Fenaux, P
- Dreyfus, F
Producer: 20111214
In:
Leukemia research vol. 35
Availability: No items available.
|